Richard U. de Schutter, Director at Valeant Pharmaceuticals International, Inc. (VRX), bought 20,000 shares at $13.90 ($278K) on 2017-05-11, disclosed to the SEC on 2017-05-15.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |
| BHC | BUY | 2018-09-17 | $3.0M | — | Filing → |
| VRX | BUY | 2018-07-03 | $218K | — | Filing → |
| VRX | BUY | 2018-05-17 | $327K | — | Filing → |